= Discovery stage. (16.60%, 2024)
= Translation stage. (37.02%, 2024)
= Clinically available. (46.38%, 2024)
MSACL 2024 : Session
MSACL 2024 Abstract
Self-Classified Topic Area(s):
Imaging
> Imaging
Podium Presentation
in De Anza 1 on Thursday at 14:10
(Chair: Erin Seeley / Jessica Moore)
Discussion on the Pros and Cons of Working with Fresh Frozen versus FFPE Tissue
Discussion Session
(Presenter)
Abstract
Session Discussion.
Financial Disclosure
Description
Y/N
Source
Grants
no
Salary
no
Board Member
no
Stock
no
Expenses
no
IP Royalty
no
Planning to mention or discuss specific products or technology of the company(ies) listed above:
no
= Discovery stage. (16.60%, 2024)
= Translation stage. (37.02%, 2024)
= Clinically available. (46.38%, 2024)
